Exact Sciences Announces Preliminary Fourth Quarter 2022 Results
Preliminary fourth quarter highlights: Expected total fourth quarter revenue, excluding COVID-19 testing, increased 28% compared to the fourth quarter 2021,...
Source: prnewswire.com
Oncomap Extra News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Oncomap Extra. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Oncomap Extra Today - Breaking & Trending Today
Exact Sciences Announces Preliminary Fourth Quarter 2022 Results
Preliminary fourth quarter highlights: Expected total fourth quarter revenue, excluding COVID-19 testing, increased 28% compared to the fourth quarter 2021,...
Source: prnewswire.com
Exact Sciences Presents First Time Data Detailing Ability to Predict Radiation Therapy Benefit in Breast Cancer Patients
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today shared initial clinical validation data...
Source: prnewswire.com
Exact Sciences Highlights the Impact of Precision Oncology Portfolio on Breast Cancer Treatment with 10 New Data Presentations at SABCS® 2022
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that new data presentations...
Source: prnewswire.com
EXACT SCIENCES CORP: Exact Sciences Highlights the Impact of Precision Oncology Portfolio on Breast Cancer Treatment with 10 New Data Presentations at SABCS 2022
New independent clinical evidence from the pivotal TAILORx and RxPONDER trials support the role of the Oncotype DX Breast Recurrence Score test, the only genomic test to predict chemotherapy
Source: finanznachrichten.de